Lataa...
Heterogeneity in chronic myeloid leukaemia dynamics during imatinib treatment: role of immune responses
Previous studies have shown that during imatinib therapy, the decline of chronic myeloid leukaemia BCR-ABL transcript numbers involves a fast phase followed by a slow phase in averaged datasets. Drug resistance leads to regrowth. In this paper, variation of treatment responses between patients is ex...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
The Royal Society
2010
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2871874/ https://ncbi.nlm.nih.gov/pubmed/20147328 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1098/rspb.2009.2179 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|